🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Lozenge(s) Serving Size
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 80.0mg (136 products)
Median 80.0mg This product: 80mg

Other Ingredients

Mannitol Sorbitol natural Chocolate flavor Hydroxypropyl Methylcellulose natural Peppermint flavor Silica Stearic Acid Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (79% of products) Nutrient (2% of products) No Claim (1% of products)

Target Groups

Women (not pregnant or lactating) Adult Female (18 - 50 Years) Menopause Seniors/Mature (>50 Years) - Women ONLY

Product Information

📋 Directions for Use

Suggested Use: 1 lozenge daily. For best results, allow to dissolve in the mouth before swallowing. May also be swallowed. For best results, use this product for at least 4 weeks.

⚠️ Warnings & Precautions

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

🧪 Formulation Notes

May help reduce hot flashes associated with menopause

Source Naturals Cimi-Fem offers you black cohosh as an extract standardized to 2.5% triterpene glycosides. Cimi-Fem contains a black cohosh, shown clinically to reduce some of the normal discomforts of menopause, including hot flashes and occasional anxiety. Cimi-Fem is delivered in a quick-dissolving chocolate peppermint flavored lozenge that does not have to be swallowed and is easy to take once daily.

Product Details

UPC / SKU 0 21078 01068 5
DSLD Entry Date 2020-02-26
Product Type Botanical
Form Lozenge
DSLD ID 213892
Data Updated 2026-04-11

Research Evidence

31 Research Sources
49 Avg Quality Score
23 Systematic Review
5 Meta Analysis
1 Rct
1 Openfda Safety
B [Efficacy of black cohosh extracts for improving low estrogen status induced by postoperative GnRHa treatment in patients with endometriosis: a systematic review]
Systematic Review Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020
B Black cohosh (Cimicifuga spp.) for menopausal symptoms
Meta Analysis The Cochrane database of systematic reviews 2012
B Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Systematic Review BJOG : an international journal of obstetrics and gynaecology 2017
C Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract
Meta Analysis Menopause (New York, N.Y.) 2011
C Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
Meta Analysis Climacteric : the journal of the International Menopause Society 2021
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2007
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2011
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2010
C Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Meta Analysis Menopause (New York, N.Y.) 2023
C Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Meta Analysis Alternative therapies in health and medicine 2010
View all evidence for Black Cohosh →

Compare Similar Products

View all Black Cohosh products →